Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.87 USD | -4.14% | -2.11% | +96.75% |
Mar. 15 | XBiotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 04 | XBiotech Inc. to Begin Constructing New R&D Facility on Its 48-Acre Campus | CI |
Financials (USD)
Sales 2022 | 4.01 | Sales 2023 | - | Capitalization | 122M |
---|---|---|---|---|---|
Net income 2022 | -32M | Net income 2023 | -24M | EV / Sales 2022 | -27,590,059 x |
Net cash position 2022 | 217M | Net cash position 2023 | 200M | EV / Sales 2023 | - |
P/E ratio 2022 |
-3.25
x | P/E ratio 2023 |
-4.94
x | Employees | 82 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 56.38% |
1 day | -4.14% | ||
1 week | -2.11% | ||
Current month | -3.20% | ||
1 month | -1.50% | ||
3 months | +87.38% | ||
6 months | +96.75% | ||
Current year | +96.75% |
Managers | Title | Age | Since |
---|---|---|---|
John Simard
CEO | Chief Executive Officer | 62 | 05-03-21 |
Angela Hu
DFI | Director of Finance/CFO | 40 | 14-12-31 |
Mark Ziats
CTO | Chief Tech/Sci/R&D Officer | - | 21-08-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Donald MacAdam
BRD | Director/Board Member | 76 | 18-03-19 |
William McKenzie
BRD | Director/Board Member | 76 | 09-01-31 |
John Simard
CEO | Chief Executive Officer | 62 | 05-03-21 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 7.87 | -4.14% | 59,355 |
24-04-25 | 8.21 | +1.73% | 45,963 |
24-04-24 | 8.07 | -1.34% | 67,351 |
24-04-23 | 8.18 | +2.89% | 154,408 |
24-04-22 | 7.95 | -1.12% | 58,090 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+96.75% | 240M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- XBIT Stock